L04AJ02 Ravulizumab
ATC class of level 5 – chemical substance
This page lists the patient medication information or the product monograph for 2 drugs in this drug class.
- 2 prescription (Rx)
Active ingredient: Ravulizumab – all drugs with this active ingredient, also in combination.
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,069 drugs
- L04 Immunosuppressants 246 drugs
- L04A Immunosuppressants 246 drugs
- L04AJ02 Ravulizumab 2 drugs
- L04A Immunosuppressants 246 drugs
- L04 Immunosuppressants 246 drugs
Drugs in the class
| Drug | Rx or OTC |
|---|---|
| Ultomiris (Alexion Pharma, 10 mg) | prescription (Rx) |
| Ultomiris (Alexion Pharma, 300 mg, 1100 mg) | prescription (Rx) |
Other classes of the same level
- L04AJ01 Eculizumab 3 drugs
- L04AJ03 Pegcetacoplan 1 drug
- L04AJ05 Avacopan 1 drug
- L04AJ06 Zilucoplan 1 drug
- L04AJ07 Crovalimab 1 drug
- L04AJ08 Iptacopan 1 drug
- L04AJ09 Danicopan 1 drug
Other names of the drug class
- German (Switzerland): L04AJ02 Ravulizumab
- French (Switzerland): L04AJ02 Ravulizumab
- Italian (Switzerland): L04AJ02 Ravulizumab
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L04AJ02
Ask your doctor or pharmacist for advice.